ALIVUS LIFE SCIENCES LTD.
|
Market Cap.(`)
|
13702.38 Cr.
|
P/BV
|
5.40
|
Book Value (`)
|
207.17
|
|
52 Week High/Low ( ` )
|
1335/677
|
FV/ML
|
2/1
|
P/E(X)
|
29.10
|
|
Book Closure
|
17/10/2023
|
EPS (`)
|
38.43
|
Div Yield (%)
|
0.00
|
(` in Crs.)
You can view the Standalone
Cash Flow
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 631.29 | 628.61 | 564.93 | 470.94 | 421.07 |
| | | | | | |
| Net CashFlow From Operating Activities | 413.52 | 313.40 | 597.59 | 388.11 | 195.01 |
| Net Cash Used In Investing Activities | -116.48 | -154.15 | -122.23 | -68.73 | -50.52 |
| Net Cash Used From Financing Activities | -279.44 | -387.59 | -78.80 | -213.78 | -136.55 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 17.59 | -228.33 | 396.56 | 105.60 | 7.94 |
| Cash And Cash Equivalents Begin of Year | 283.82 | 512.16 | 115.60 | 10.00 | 2.06 |
| Cash And Cash Equivalents End Of Year | 301.41 | 283.82 | 512.16 | 115.60 | 10.00 |